Market Trends Bristol sBLA for Opdivo, Yervoy combination in colorectal cancer accepted by FDA (BMY:NYSE)By admin8996erT0allFebruary 24, 2025 hapabapa A sBLA submitted by Bristol Myers Squibb (NYSE:BMY) for a combination of Opdivo (nivolumab) + Yervoy (ipilimumab) for microsatellite…
Market Trends Potential Rio Tinto-Glencore combination considered poor fit, unlikely to happenBy admin8996erT0allJanuary 19, 2025 BeyondImages/iStock via Getty Images Rio Tinto (NYSE:RIO) and Glencore (OTCPK:GLCNF) (OTCPK:GLNCY) reportedly discussed a potential merger for months at the…
